The Race for an Ebola Vaccine

Test tubes and vials sit in a laboratory at the Bavarian Nordic biotechnology company, which is working on an Ebola vaccine.Over the summer, as it became clear that the Ebola outbreak in West Africa was one of the worst public-health emergencies in recent memory, executives at Merck met at the company’s New Jersey headquarters to figure out how to respond. Public-health organizations were also getting in touch with people at Merck, asking for help. At several meetings, the executives cycled through the possibilities: Should they donate medicines? Financially support the relief efforts? Help to develop treatments for Ebola? (read more)